Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
Clinical trial NCT07053059 · RECRUITING
Trial details
- NCT number
- NCT07053059
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-26
- Primary completion
- 2028-05-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.